Harbor Capital Advisors Inc. Sells 17,027 Shares of Encompass Health Corporation $EHC

Harbor Capital Advisors Inc. lowered its stake in shares of Encompass Health Corporation (NYSE:EHC) by 25.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 51,137 shares of the company’s stock after selling 17,027 shares during the period. Harbor Capital Advisors Inc.’s holdings in Encompass Health were worth $6,271,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Pinnacle Wealth Planning Services Inc. raised its position in Encompass Health by 4.0% during the first quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock worth $263,000 after acquiring an additional 99 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its stake in shares of Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after purchasing an additional 115 shares during the last quarter. Arlington Trust Co LLC raised its holdings in shares of Encompass Health by 22.9% in the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock valued at $68,000 after purchasing an additional 125 shares during the period. IFP Advisors Inc lifted its stake in Encompass Health by 5.9% in the 1st quarter. IFP Advisors Inc now owns 2,814 shares of the company’s stock valued at $285,000 after purchasing an additional 158 shares during the last quarter. Finally, Merit Financial Group LLC grew its holdings in Encompass Health by 4.1% during the first quarter. Merit Financial Group LLC now owns 4,220 shares of the company’s stock worth $427,000 after purchasing an additional 166 shares during the period. 97.25% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 2.10% of the stock is owned by company insiders.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $123.67 on Wednesday. The firm has a 50 day moving average of $117.72 and a 200-day moving average of $113.18. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $127.15. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The stock has a market capitalization of $12.46 billion, a PE ratio of 24.20, a PEG ratio of 2.18 and a beta of 0.92.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same period last year, the firm posted $1.11 earnings per share. The firm’s quarterly revenue was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, equities research analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.19 per share. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. This is an increase from Encompass Health’s previous quarterly dividend of $0.17. Encompass Health’s dividend payout ratio is currently 13.31%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on EHC. UBS Group upped their price objective on Encompass Health from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Truist Financial boosted their target price on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a report on Thursday, August 14th. KeyCorp increased their price target on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday. Bank of America lifted their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Finally, Stephens raised shares of Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 price objective on the stock in a research report on Thursday, June 5th. One research analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $138.43.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.